KP Biomedical Engineering

-Glaukos Announces Participation in Upcoming Investor ConferencesALISO VIEJO, Calif.--(BUSINESS WIRE)

--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 12:45 p.m. ET in Boston, MA Morgan Stanley 22nd Annual Global Healthcare Conference

-ECI Listed in INC's 5000 Fastest Growing Companies in America for 2024MARLBOROUGH, Mass.--(BUSINESS WIRE)

--ECI (Enhanced Compliance Inc.), a leading provider of regulatory, quality, and engineering services for the life sciences industry, is pleased to announce its inclusion in the 2024 INC 5000 Fast Growing Companies list, with 203% growth over three years. This accolade highlights ECI’s rapid expansion, innovative solutions, and dedication to customer satisfaction.

-Hematologic Malignancies Testing Research Report 2024: Strategic Partnerships to Enhance Diagnostic Capabilities in Emerging Markets Fueling Opportunities - Global Forecast to 2033 - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)

--The "Hematologic Malignancies Testing Market - A Global and Regional Analysis: Focus on Product, Platform, Disease, End User, and Region - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering. The global hematologic malignancies testing market was valued at $3.54 billion in 2023 and is expected to reach $13.50 billion by 2033, growing at a CAGR of 14.09% during the forecast period 2024-2033

-Audax Private Equity to Acquire Avantor’s Clinical Services BusinessSAN FRANCISCO & BOSTON--(BUSINESS WIRE)

--Audax Private Equity (“Audax”) announced today it has entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. (NYSE: AVTR) (“Clinical Services” or “the Company”). The deal is expected to close in the fourth quarter and is subject to regulatory approvals. Clinical Services provides clinical trial and laboratory supply chain services to pharmaceutical and biotechnology companies

-NOWDiagnostics First To Know? Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter UseSPRINGDALE, Ark.--(BUSINESS WIRE)

--NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know? Syphilis Test for OTC use. First To Know? is the first and only rapid syphilis test in the U.S. that provides an in-home result in 15 minutes with a single drop of blood.

-Medical Laser Technologies World Market Report 2024: Advancing Medicine - The Future of Laser Surgery and Low-Level Laser Therapy - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)

--The "Medical Laser Technologies World Market" report has been added to ResearchAndMarkets.com's offering. The medical laser technologies market is experiencing a rapid growth, driven by factors such as the increasing demand for minimally invasive procedures, growing preference for aesthetic and cosmetic surgeries, and rising incidences of vascular and ocular disorders.

-Microelectronic Medical Implants Products, Technologies & Opportunities Report 2024-2029 - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)

--The "Microelectronic Medical Implants: Products, Technologies & Opportunities 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Microelectronic Medical Implants Market was valued at USD 49 Billion in 2024 and is forecast to reach USD 85.1 Billion by 2029, growing at a CAGR of 11.7%.

-QuidelOrtho to Participate in Upcoming Investor ConferencesSAN DIEGO--(BUSINESS WIRE)

--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will attend two upcoming investor conferences.

-GE HealthCare to Embark on a Collaboration to Elevate Women’s ImagingSAN DIEGO--(BUSINESS WIRE)

--GE HealthCare today announced a collaboration with the University of California San Diego School of Medicine to investigate advanced magnetic resonance imaging (MRI) protocols and techniques for female-specific diseases and conditions of the pelvis and develop comprehensive educational materials for clinicians. The goal of the project is to elevate women’s pelvic health, filling an important gap in medical research and care.

-ZOLL announces successful bid to acquire ventilator business from Vyaire MedicalCHELMSFORD, Mass.--(BUSINESS WIRE)

--ZOLL?, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it is the winning bidder in an auction to acquire Vyaire Medical’s ventilator business as part of Vyaire’s Chapter 11 bankruptcy proceedings. Completion of the acquisition is subject to court approval at a sale hearing and dependent on a successful closing that is anticipated to occur in the coming weeks.

-Guard Medical Announces FDA 510(k) Clearance for Additional Large Sizes of Its Novel NPseal? NPWT Surgical Dressing, Unlocking the Orthopedic MarketMIAMI--(BUSINESS WIRE)

--Privately-held company Guard Medical Inc. today announces FDA 510(k) clearance for additional large sizes (surgical wounds up to 25cm) of its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal for the treatment of closed surgical incisions. NPseal is an easy-to-use, affordable, and cost-effective NPWT surgical dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.

-CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare ConferenceLARGO, Fla.--(BUSINESS WIRE)

--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 8:00 a.m. ET on Wednesday, September 4, 2024.

-Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide RecallSAN DIEGO--(BUSINESS WIRE)

--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) today announced the planned release of version 2.8.2 of its Apple iOS t:connect mobile app in the United States on August 20, 2024 to correct an issue described in a March 2024 recall that can cause rapid depletion of a user’s t:slim X2 insulin pump battery.

-AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid IndicationsBOSTON--(BUSINESS WIRE)

--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy platform, today announced it has entered into a strategic agreement with the Jacobs Institute, a nonprofit medical device innovation center in Buffalo, N.Y., led by Adnan Siddiqui, M.D.

-PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & DevelopmentBOSTON--(BUSINESS WIRE)

--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development (R&D), effective immediately.

-Carilion Clinic Further Expands Quality Cardiac Care Access with Latest Philips Innovations at Region’s Premier Cardiovascular Institute at Crystal Spring Tower in VirginiaCAMBRIDGE, Mass. & ROANOKE, Va.--(BUSINESS WIRE)

--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a not-for-profit health care organization serving more than one million people in Virginia and West Virginia, today announced Carilion will adopt the Philips cardiovascular care ecosystem of solutions at the future home of its Cardiovascular Institute at Crystal Spring Tower.

-Bio-Rad Appoints Jon DiVincenzo President, Chief Operating OfficerHERCULES, Calif.--(BUSINESS WIRE)

--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9, 2024, replacing Andy Last, who is retiring.

-Autoinjectors Strategic Business Report 2023-2030: Rapid Shift from Self-Injectors to Autoinjectors for Easy and Safe Administration of Drugs Drives Demand - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)

--The "Autoinjectors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Autoinjectors is estimated at US$59.7 Billion in 2023 and is projected to reach US$168.2 Billion by 2030, growing at a CAGR of 13.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

-SoClean Obtains FDA ClearancePETERBOROUGH, N.H.--(BUSINESS WIRE)

-- SoClean, a pioneer in bacterial reduction systems for CPAP hoses and masks, is pleased to announce it has been granted De Novo clearance by the FDA for the SoClean 3+. The SoClean 3+ is the only FDA cleared product intended to be used as an adjunct to reduce bacterial populations on certain compatible home use CPAP mask and ventilation hoses after cleaning.

-EMulate Therapeutics Inc. Announces Publication of Pre-Clinical Mouse Model Demonstrating Direct Evidence of Immune Checkpoint Receptor Knock-Down in a Mouse Glioblastoma ModelBELLEVUE, Wash.--(BUSINESS WIRE)

--EMulate Therapeutics, Inc. (“Emulate”) announces the Open Journal of Biophysics (OJBIPHY), publisher of over 200 peer-reviewed open access journals, has accepted its manuscript, titled “Magnetic Field Emulations of Small Inhibitor RNA: Effects on Implanted GL261 Tumors in C57BL/6 Immune Competent Mice” for publication.

-Covalon Announces Strong Third Quarter Fiscal 2024 ResultsMISSISSAUGA, Ontario--(BUSINESS WIRE)

--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 third quarter results for the period ended June 30, 2024. “We delivered a very successful Q3 – solid performance on growth, margins and operating expenses all led to another strong quarter of profitability,” said Brent Ashton, Covalon’s Chief Executive Officer.

-Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare ConferenceIRVINE, Calif.--(BUSINESS WIRE)

--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the Wells Fargo Healthcare Conference on Thursday, Sept. 5, 2024. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:15 a.m. ET.

-Delphinus Medical Technologies Awarded Technology Breakthrough From Premier, Inc.NOVI, Mich.--(BUSINESS WIRE)

--Delphinus Medical Technologies today announced that it has been awarded a national group purchasing agreement and Technology Breakthrough designation for its SoftVue? Breast Ultrasound Tomography (UST) from Premier, inc. Delphinus is now listed as a top supplier for Premier’s members, who at their discretion, can take advantage of special pricing and terms pre-negotiated by Premier for SoftVue.

-Podimetrics Partners with HTEC to Develop Industry-Leading Patient Care TechnologySAN MATEO, Calif.--(BUSINESS WIRE)

--HTEC, a global end-to-end digital product development and engineering services company, is proud to announce a collaboration with Podimetrics. Podimetrics is the creator of the SmartMat? and provider of integrated clinical and patient support services saving the limbs and lives of people living with complex diabetes by providing cutting-edge technology and personalized patient remote monitoring.

-Automated Industrial Robotics Inc. Acquires Sewtec AutomationLOS ANGELES--(BUSINESS WIRE)

--Automated Industrial Robotics Inc. (“AIR” or the “Company”) today announced the acquisition of Sewtec Automation (“Sewtec”), a leading industrial automation company based in the United Kingdom. The transaction expands AIR’s geographic footprint, strengthens its engineering capabilities and further positions the Company to capitalize on the increasing global demand for manufacturing automation solutions across a diversified customer base.

-NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersELMSFORD, N.Y.--(BUSINESS WIRE)

--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield?, PainShield? and WoundShield? Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to its stockholders from its Chief Executive Officer, Brian Murphy, providing a review of the second quarter financials and recent business developments.

-Tris Pharma Initiates ALLEVIATE-1 and ALLEVIATE-2, Pivotal Phase 3 Trials Investigating Cebranopadol, a First-in-Class Compound with a Novel Mechanism of Action to Treat PainMONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)

--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, announced today the initiation of ALLEVIATE-1 and ALLEVIATE-2, pivotal Phase 3 trials evaluating the efficacy and safety of cebranopadol for the treatment of moderate-to-severe acute pain.

-Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceWALTHAM, Mass.--(BUSINESS WIRE)

--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York.

-Nordson Corporation Completes Acquisition of Atrion CorporationWESTLAKE, Ohio--(BUSINESS WIRE)

--Nordson Corporation (Nasdaq: NDSN) (the “Company” or “Nordson”) has completed the acquisition of Atrion Corporation (“Atrion”), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions. The completion of the transaction follows the Company’s May 28, 2024 announcement that it had entered into an agreement to acquire the business.

-Trinity Life Sciences Announces New Customer Engagement Solutions Leveraging Its Deep Commercial Insight and Recognized Technology PlatformWALTHAM, Mass.--(BUSINESS WIRE)

--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform.

-GE HealthCare management to present at September investor conferencesCHICAGO--(BUSINESS WIRE)

--GE HealthCare (Nasdaq: GEHC) announced today that management will present at the following September investor conferences. 2024 Wells Fargo Healthcare Conference in Boston on September 4, 2024 at 10:15 am ET/9:15 am CT Morgan Stanley 22nd Annual Global Healthcare Conference in New York on September 5, 2024 at 1:05 pm ET/12:05 pm CT

-IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare ConferenceWESTBROOK, Maine--(BUSINESS WIRE)

--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 from 11:30 am – 12:05 pm (EDT).

-HealthTrust Performance Group Honors Suppliers for Partnership and Service ExcellenceORLANDO, Fla.--(BUSINESS WIRE)

--HealthTrust Performance Group, a leading healthcare performance improvement organization, has named Foodbuy, Vital Care Industries and Cardinal Health as recipients of Supplier Excellence Awards for 2024. The annual awards acknowledge supplier-partners for best-in-class service and superior value in supporting the HealthTrust membership.

-VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon BiosciencesCHARLOTTESVILLE, Va.--(BUSINESS WIRE)

--VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio.

-AtriCure Receives Expanded CE-Mark Indication for AtriClip? Devices for the Reduction of Stroke in Patients with Atrial FibrillationMASON, Ohio--(BUSINESS WIRE)

--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has received an expanded indication for the AtriClip? in CE-marked countries in Europe.

-AISAP’s CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Assessment Software Receives FDA ClearanceBOSTON--(BUSINESS WIRE)

--AISAP, a medical technology company developing AI-powered Point-of-Care Assisted Diagnosis (POCAD?) solutions to transform medical ultrasound, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its first-of-a-kind, AI-powered AISAP CARDIO point-of-care ultrasound (POCUS) software platform.

-ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business UpdateANN ARBOR, Mich.--(BUSINESS WIRE)

--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS?), reports financial results for the three and six months ended June 30, 2024, as filed in a Form 10-Q on August 14, 2024, and provides the following business update: New executive team Subsequent to quarter-end, ENDRA announced leadership changes.

-Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare ConferenceHERCULES, Calif.--(BUSINESS WIRE)

--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company’s Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during Wells Fargo’s 2024 Healthcare Conference on Wednesday, September 4, at 2:15 PM Eastern Time (11:15 AM Pacific Time).

-Paragonix Technologies Signs Definitive Agreement to be Acquired by GetingeWALTHAM, Mass.--(BUSINESS WIRE)

--Paragonix Technologies, a leading organ transplant company, announced today that it has entered into a definitive agreement to be acquired by Getinge. This strategic acquisition will enhance Getinge’s global healthcare portfolio to also address needs in solid organ transplantation.